Lanraplenib [CAS 1800046-95-0]
Partner: MedChemexpress LLC
| CAS No: | 1800046-95-0 |
| Applications: | COVID-19-immunoregulation |
| MW: | 443.50 |
| Formula: | C23H25N9O |
| SMILES: | NC1=CN=CC(C2=CN3C(C(NC4=CC=C(N5CCN(C6COC6)CC5)C=C4)=N2)=NC=C3)=N1 |
| Purity: | 99.12 |
| Description: | Lanraplenib (GS-9876) is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases. Lanraplenib (GS-9876) inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans[1][2][3]. |
| Shipping Conditions: | Ship at ambient |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
